443 related articles for article (PubMed ID: 29588466)
1. Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms.
Mancini SJ; Boyd D; Katwan OJ; Strembitska A; Almabrouk TA; Kennedy S; Palmer TM; Salt IP
Sci Rep; 2018 Mar; 8(1):5276. PubMed ID: 29588466
[TBL] [Abstract][Full Text] [Related]
2. Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells.
Uthman L; Kuschma M; Römer G; Boomsma M; Kessler J; Hermanides J; Hollmann MW; Preckel B; Zuurbier CJ; Weber NC
Cardiovasc Drugs Ther; 2021 Dec; 35(6):1083-1094. PubMed ID: 33048256
[TBL] [Abstract][Full Text] [Related]
3. Interactions of TLR4 and PPARγ, Dependent on AMPK Signalling Pathway Contribute to Anti-Inflammatory Effects of Vaccariae Hypaphorine in Endothelial Cells.
Sun H; Zhu X; Lin W; Zhou Y; Cai W; Qiu L
Cell Physiol Biochem; 2017; 42(3):1227-1239. PubMed ID: 28683454
[TBL] [Abstract][Full Text] [Related]
4. The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice.
Day EA; Ford RJ; Lu JH; Lu R; Lundenberg L; Desjardins EM; Green AE; Lally JSV; Schertzer JD; Steinberg GR
Biochem J; 2020 Jun; 477(12):2347-2361. PubMed ID: 32510137
[TBL] [Abstract][Full Text] [Related]
5. Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathway.
Dabour MS; Abdelgawad IY; Grant MKO; El-Sawaf ES; Zordoky BN
Biomed Pharmacother; 2023 Aug; 164():114907. PubMed ID: 37247463
[TBL] [Abstract][Full Text] [Related]
6. Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway.
Zhou J; Zhu J; Yu SJ; Ma HL; Chen J; Ding XF; Chen G; Liang Y; Zhang Q
Biomed Pharmacother; 2020 Dec; 132():110821. PubMed ID: 33068934
[TBL] [Abstract][Full Text] [Related]
7. The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.
Hawley SA; Ford RJ; Smith BK; Gowans GJ; Mancini SJ; Pitt RD; Day EA; Salt IP; Steinberg GR; Hardie DG
Diabetes; 2016 Sep; 65(9):2784-94. PubMed ID: 27381369
[TBL] [Abstract][Full Text] [Related]
8. A769662 Inhibits Insulin-Stimulated Akt Activation in Human Macrovascular Endothelial Cells Independent of AMP-Activated Protein Kinase.
Strembitska A; Mancini SJ; Gamwell JM; Palmer TM; Baillie GS; Salt IP
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563079
[TBL] [Abstract][Full Text] [Related]
9. Canagliflozin Inhibits Glioblastoma Growth and Proliferation by Activating AMPK.
Shoda K; Tsuji S; Nakamura S; Egashira Y; Enomoto Y; Nakayama N; Shimazawa M; Iwama T; Hara H
Cell Mol Neurobiol; 2023 Mar; 43(2):879-892. PubMed ID: 35435536
[TBL] [Abstract][Full Text] [Related]
10. The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms.
Hwang HJ; Chung HS; Jung TW; Ryu JY; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
Mol Cell Endocrinol; 2015 Apr; 405():25-34. PubMed ID: 25661535
[TBL] [Abstract][Full Text] [Related]
11. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells.
Hattori Y; Suzuki K; Hattori S; Kasai K
Hypertension; 2006 Jun; 47(6):1183-8. PubMed ID: 16636195
[TBL] [Abstract][Full Text] [Related]
13. Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement.
Alsereidi FR; Khashim Z; Marzook H; Gupta A; Al-Rawi AM; Ramadan MM; Saleh MA
Curr Probl Cardiol; 2024 May; 49(5):102524. PubMed ID: 38492622
[TBL] [Abstract][Full Text] [Related]
14. Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake.
Kaji K; Nishimura N; Seki K; Sato S; Saikawa S; Nakanishi K; Furukawa M; Kawaratani H; Kitade M; Moriya K; Namisaki T; Yoshiji H
Int J Cancer; 2018 Apr; 142(8):1712-1722. PubMed ID: 29205334
[TBL] [Abstract][Full Text] [Related]
15. Distinctive effects of SGLT2 inhibitors on angiogenesis in zebrafish embryos.
Huttunen R; Sainio A; Hjelt A; Haapanen-Saaristo AM; Määttä J; Rummukainen P; Paatero I; Järveläinen H
Biomed Pharmacother; 2022 Dec; 156():113882. PubMed ID: 36265308
[TBL] [Abstract][Full Text] [Related]
16. Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells.
Xu C; Wang W; Zhong J; Lei F; Xu N; Zhang Y; Xie W
Biochem Pharmacol; 2018 Jun; 152():45-59. PubMed ID: 29551587
[TBL] [Abstract][Full Text] [Related]
17. Quercetin Inhibits the Production of IL-1β-Induced Inflammatory Cytokines and Chemokines in ARPE-19 Cells via the MAPK and NF-κB Signaling Pathways.
Cheng SC; Huang WC; S Pang JH; Wu YH; Cheng CY
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31212975
[TBL] [Abstract][Full Text] [Related]
18. Implication of S-adenosylhomocysteine hydrolase in inhibition of TNF-alpha- and IL-1beta-induced expression of inflammatory mediators by AICAR in RPE cells.
Qin S; Ni M; De Vries GW
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1274-81. PubMed ID: 18326758
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-
Lee N; Heo YJ; Choi SE; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
J Immunol Res; 2021; 2021():9944880. PubMed ID: 34124273
[TBL] [Abstract][Full Text] [Related]
20. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice.
Abdelrahman AM; Al Suleimani Y; Shalaby A; Ashique M; Manoj P; Nemmar A; Ali BH
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jan; 392(1):45-53. PubMed ID: 30206656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
